{"id":10519,"date":"2025-01-31T11:57:36","date_gmt":"2025-01-31T08:57:36","guid":{"rendered":"https:\/\/ozgurkilickesmez.com\/?p=10519"},"modified":"2026-10-13T22:12:51","modified_gmt":"2026-10-13T19:12:51","slug":"middle-meningeal-artery-embolization-in-chronic-subdural-hemorrhage","status":"publish","type":"post","link":"https:\/\/ozgurkilickesmez.com\/en\/middle-meningeal-artery-embolization-in-chronic-subdural-hemorrhage\/","title":{"rendered":"Middle Meningeal Artery Embolization for Chronic Subdural Hematoma"},"content":{"rendered":"

Middle meningeal artery embolization is a modern treatment for chronic subdural hemorrhage. It targets abnormal vascular connections to prevent rebleeding and reduce the need for repeated surgical drainage.<\/span><\/p>\n

This procedure involves navigating a catheter into the middle meningeal artery and injecting embolic material to occlude fragile vessels. It offers a less invasive alternative to craniotomy.<\/span><\/p>\n

Clinical studies show significant reduction in recurrence rates of chronic subdural hematoma following embolization. It is particularly useful for elderly patients or those with high surgical risks.<\/span><\/p>\n

Post-procedure recovery is generally quick, with minimal complications. Middle meningeal artery embolization is now widely accepted as an effective and safe adjunct to conventional neurosurgical management.<\/span><\/p>\n\n\n\n\n\n\n\n\n\n\n
Definition<\/td>\nMiddle meningeal artery embolization (MMAE) is an interventional radiology procedure in which the bleeding vessel is occluded to stop blood flow, used in the treatment of chronic subdural hematoma (CSDH).<\/td>\n<\/tr>\n
Indications<\/td>\nChronic subdural hematoma (especially recurrent or surgery\u2011resistant cases), minimally symptomatic or non\u2011surgical CSDH, prevention of postoperative hematoma recurrence.<\/td>\n<\/tr>\n
Mechanism of Action<\/td>\nThe middle meningeal artery (MMA) is one of the main vessels sustaining the subdural hematoma. Embolization helps hematoma regression and prevents recurrence by occluding this artery.<\/td>\n<\/tr>\n
Procedure<\/td>\n1. The patient is prepared under local anesthesia or mild sedation.
\n2. A catheter is introduced via the groin to reach the MMA.
\n3. Fluoroscopy (angiography) is used to visualize the vessel.
\n4. Embolic agents (e.g., particles, liquid embolics) are injected via a microcatheter to occlude the vessel.
\n5. The patient is observed after the procedure.<\/td>\n<\/tr>\n
Advantages<\/td>\nMinimally invasive, no general anesthesia required, may reduce need for craniotomy or burr\u2011hole drainage, lowers risk of hematoma recurrence.<\/td>\n<\/tr>\n
Possible Complications<\/td>\nRisk of stroke if embolic material reaches unintended cerebral vessels, bleeding, infection, transient headache, allergic reaction to contrast agent.<\/td>\n<\/tr>\n
Duration of Effect<\/td>\nAfter successful embolization, the hematoma typically shrinks and resolves over weeks to months. Follow\u2011up imaging monitors the process.<\/td>\n<\/tr>\n
Contraindications<\/td>\nActive intracranial bleeding, significant vascular anomalies (e.g., aneurysm, AVM), renal failure (contrast agent risk).<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
\n
\n

Table of Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n